FDA advisory committee to review Guradant Health's colorectal cancer blood test

If approved, the test would become the first approved blood test for colorectal cancer that would qualify for Medicare reimbursement

Related Keywords

United States ,Chris Evans ,Guardant Health ,Drug Administration ,Us Centers For Medicare ,Nasdaq ,Colon Cancer Coalition ,Colorectal Cancer Alliance ,Medicaid Services ,Clinical Genetics Panel ,Medical Devices Advisory Committee ,Colorectal Cancer ,